SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CICCONE, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.428
AS - Asia 1.987
EU - Europa 1.318
SA - Sud America 289
AF - Africa 28
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.057
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.333
SG - Singapore 815
CN - Cina 651
DE - Germania 339
BR - Brasile 235
UA - Ucraina 202
GB - Regno Unito 170
IT - Italia 165
HK - Hong Kong 149
TR - Turchia 134
VN - Vietnam 121
FI - Finlandia 98
SE - Svezia 73
RU - Federazione Russa 67
FR - Francia 55
CA - Canada 50
MX - Messico 36
PL - Polonia 35
IN - India 31
CZ - Repubblica Ceca 25
AR - Argentina 21
BE - Belgio 20
ES - Italia 17
ID - Indonesia 17
NL - Olanda 17
JP - Giappone 16
ZA - Sudafrica 14
IQ - Iraq 13
BD - Bangladesh 12
LT - Lituania 12
EC - Ecuador 11
RO - Romania 6
VE - Venezuela 6
AT - Austria 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
MA - Marocco 4
AU - Australia 3
CH - Svizzera 3
CO - Colombia 3
DO - Repubblica Dominicana 3
KR - Corea 3
MY - Malesia 3
PY - Paraguay 3
UY - Uruguay 3
BG - Bulgaria 2
EG - Egitto 2
IE - Irlanda 2
KG - Kirghizistan 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GF - Guiana Francese 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
SR - Suriname 1
TO - Tonga 1
UZ - Uzbekistan 1
Totale 8.057
Salva come PNG Salva come JPEG
Città #
Singapore 493
Woodbridge 466
Ashburn 462
Fairfield 391
Houston 320
Beijing 272
Chandler 258
Jacksonville 224
Santa Clara 204
Ann Arbor 179
Seattle 160
Hong Kong 148
Cambridge 147
Wilmington 136
Los Angeles 113
New York 103
Munich 87
Dallas 76
Nanjing 71
Izmir 68
Princeton 53
Ferrara 50
Shanghai 50
Boardman 40
San Diego 40
Ho Chi Minh City 38
Addison 37
Milan 35
Warsaw 33
Turku 32
São Paulo 30
Shenyang 26
Bremen 25
Hanoi 25
London 25
Montreal 23
Buffalo 22
Helsinki 21
Mexico City 21
Brussels 20
Nanchang 20
Poplar 18
Stockholm 18
Denver 17
Brooklyn 15
Hebei 15
Brno 14
Hefei 14
Manchester 14
Falkenstein 13
Frankfurt am Main 13
Tokyo 13
Changsha 12
Chennai 12
Chicago 12
Jinan 12
Orem 12
San Francisco 12
San Jose 12
Jakarta 11
Johannesburg 11
Tianjin 11
Auburn Hills 10
Augusta 10
Moscow 10
Olomouc 10
Rio de Janeiro 10
Atlanta 9
Haiphong 9
Toronto 9
Zhengzhou 9
Boston 8
Mumbai 8
Orange 8
Phoenix 8
Bologna 7
Dearborn 7
Jiaxing 7
Nuremberg 7
Ottawa 7
San Mateo 7
Ankara 6
Biên Hòa 6
Guangzhou 6
Guayaquil 6
Baghdad 5
Falls Church 5
Mountain View 5
Norwalk 5
Redwood City 5
Washington 5
Amsterdam 4
Columbus 4
Da Nang 4
Leawood 4
Minerbe 4
Philadelphia 4
Querétaro 4
Raleigh 4
Redmond 4
Totale 5.575
Salva come PNG Salva come JPEG
Nome #
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 240
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 237
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 220
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 220
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 218
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 216
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 215
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 209
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 206
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 198
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 195
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 195
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 195
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 189
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 188
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 185
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 185
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 184
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 181
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 178
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 175
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 174
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 174
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 173
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 172
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 167
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 167
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 162
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 162
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 159
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 158
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 157
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 156
Neoplastic circulating endothelial cells in hematologic malignancies 146
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 144
Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia 143
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 142
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 135
Molecular cytogenetic lesions in chronic lymphocytic leukemia 133
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 125
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 120
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 112
Significato dell'analisi citogenetica e citogenetico-molecolare nella diagnosi e nella prognosi delle neoplasie ematologiche. Cytogenetics and molecular cytogenetics in diagnosis and prognosis of haematological malignancies 107
TRISOMY 8 IN PDGFRB-NEGATIVE CELLS IN A PATIENT WITH IMATINIB SENSITIVE CHRONIC MYELOMONOCYTIC LEUKAEMIA AND THE T(5;16)(Q33;P13)/PDGFRB/NDE1 FUSION 105
Neoplastic circulating endothelial cells in hematologic malignancies 91
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 74
Neoplastic circulating endothelial cells in hematologic malignancies. 71
null 59
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow sample. 56
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 55
null 55
null 45
Totale 8.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 569
Totale 36.650
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 85 22 74 7 86 126 56
2021/2022579 57 68 32 16 29 23 24 18 11 46 56 199
2022/2023562 55 31 24 69 111 73 31 55 60 5 26 22
2023/2024277 28 37 10 7 11 56 12 22 7 6 6 75
2024/20251.276 16 42 91 51 170 149 13 44 201 105 197 197
2025/20262.237 400 166 284 534 619 234 0 0 0 0 0 0
Totale 8.128